NeuroBo Pharmaceuticals, Inc.
NASDAQ:NRBO
2.92 (USD) • At close October 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0.004 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0.006 | 0.004 | 0.004 | 0.001 | 0 | 0.001 | 0.001 | 0.002 | 0.007 | 0.012 | 0.036 | 0.012 | 0.019 | 0.017 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| -0.006 | -0.004 | 0 | -0.001 | 0 | -0.001 | -0.001 | -0.002 | -0.007 | -0.012 | -0.036 | -0.012 | -0.019 | -0.017 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 8.074 | 4.904 | 3.861 | 2.292 | 2.364 | 0.637 | 0.305 | 0.571 | 0.982 | 0.92 | 1.997 | 1.394 | 2.012 | 1.143 | 17.779 | 1.265 | 0.674 | 2.152 | 13.78 | 1.068 | 1.234 | 1.393 | 1.833 | 3.542 | 3.96 | 4.977 | 5.08 | 6.489 | 5.837 | 5.28 | 4.839 | 1.936 | 0.789 | 1.176 | 1.464 | 1.369 | 0.952 | 0.206 |
General & Administrative Expenses
| 2.01 | 1.977 | 1.802 | 1.601 | 1.442 | 1.883 | 1.915 | 2.533 | 2.237 | 1.955 | 2.581 | 2.07 | 1.914 | 2.187 | 1.736 | 1.795 | 1.718 | 2.597 | -1.071 | 1.25 | 1.115 | 1.407 | 1.468 | 2.364 | 2.574 | 2.087 | 1.487 | 2.05 | 4.678 | 2.223 | 2.389 | 1.466 | 1.051 | 1.05 | 1.047 | 0.997 | 0.658 | 0.475 |
Selling & Marketing Expenses
| -0.006 | -0.004 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 2.004 | 1.973 | 1.802 | 1.601 | 1.442 | 1.883 | 1.915 | 2.533 | 2.237 | 1.955 | 2.581 | 2.07 | 1.914 | 2.187 | 1.736 | 1.795 | 1.718 | 2.597 | -1.071 | 1.25 | 1.115 | 1.407 | 1.468 | 2.364 | 2.574 | 2.087 | 1.487 | 2.05 | 4.678 | 2.223 | 2.389 | 1.466 | 1.051 | 1.05 | 1.047 | 0.997 | 0.658 | 0.475 |
Other Expenses
| 0 | 0 | 0.004 | 0 | 0 | 0 | 0.01 | -0.009 | -0.084 | 0 | 0 | 0 | 0 | 0 | 25.185 | 0 | 0 | -0.001 | 10.009 | -1.116 | -0.581 | -0.171 | -0.177 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 10.078 | 6.877 | 5.663 | 3.893 | 3.806 | 2.52 | 2.22 | 3.104 | 3.219 | 2.875 | 4.578 | 3.464 | 3.926 | 3.33 | 19.515 | 3.06 | 2.392 | 4.749 | 12.709 | 2.318 | 2.349 | 2.8 | 3.301 | 5.906 | 6.534 | 7.064 | 6.567 | 8.539 | 10.515 | 7.503 | 7.228 | 3.402 | 1.84 | 2.226 | 2.511 | 2.366 | 1.61 | 0.681 |
Operating Income
| -10.084 | -6.881 | -5.667 | -3.893 | -3.806 | -2.52 | -10.43 | -3.104 | -3.219 | -2.875 | -4.578 | -3.464 | -3.926 | -3.33 | -19.515 | -3.06 | -2.392 | -4.749 | -12.709 | -2.318 | -2.349 | -2.8 | -3.301 | -5.906 | -6.534 | -7.064 | -6.567 | -8.539 | -10.515 | -7.503 | -7.228 | -3.402 | -1.84 | -2.226 | -2.511 | -2.366 | -1.61 | -1.589 |
Operating Income Ratio
| 0 | 0 | -1,416.75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 0.031 | 0.167 | 0.353 | 0.075 | 3.072 | -0.084 | 5.754 | -0.009 | -0.084 | 0 | -10.706 | 0.003 | 0.005 | 0.006 | -10.163 | 0.006 | 0.008 | -0.001 | 0.754 | -1.116 | -0.581 | -0.171 | -0.177 | -0.001 | -0.144 | -0.16 | -0.179 | -0.132 | 0.013 | -0.005 | 0.001 | -0.001 | 0.449 | -0.004 | -0.196 | 0.006 | -0.001 | -0.908 |
Income Before Tax
| -10.053 | -6.714 | -5.314 | -3.818 | -0.734 | -2.604 | -4.676 | -3.113 | -3.303 | -2.875 | -4.578 | -3.461 | -3.921 | -3.324 | -19.51 | -3.054 | -2.384 | -4.73 | -11.161 | -3.43 | -2.92 | -3.801 | -3.656 | -6.079 | -6.678 | -7.224 | -6.746 | -8.671 | -10.502 | -7.496 | -7.214 | -3.878 | -1.391 | -2.103 | -2.57 | -2.569 | -1.611 | -2.279 |
Income Before Tax Ratio
| 0 | 0 | -1,328.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0 | -0.039 | -0.083 | -0.001 | -3.194 | 0.084 | -5.67 | 0.009 | -0.002 | 0 | 10.706 | 0 | -0.007 | -0.005 | -10.168 | 0 | 0 | -0.02 | -0.806 | -0.008 | -0.011 | -1.621 | 0.178 | -1.555 | -4.649 | -4.649 | 0 | 0 | 0 | -0.012 | 0 | 0.475 | 0 | -0.127 | -0.137 | 0.209 | 0 | -0.218 |
Net Income
| -10.053 | -6.714 | -5.314 | -3.818 | -0.734 | -2.688 | 0.994 | -3.122 | -3.303 | -2.875 | -4.578 | -3.461 | -3.921 | -3.324 | -19.51 | -3.054 | -2.384 | -4.73 | -11.161 | -3.43 | -2.92 | -3.801 | -3.656 | -6.079 | -6.678 | -7.224 | -6.746 | -8.671 | -10.502 | -7.496 | -7.214 | -3.878 | -1.391 | -2.103 | -2.57 | -2.569 | -1.611 | -2.279 |
Net Income Ratio
| 0 | 0 | -1,328.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -1.85 | -1.32 | -1.05 | -0.75 | -0.15 | -0.53 | 0.31 | -3.51 | -3.72 | -3.24 | -6.16 | -4.66 | -5.35 | -4.61 | -35.63 | -5.58 | -4.39 | -9.06 | -193.47 | -19.92 | -16.95 | -199.84 | -192.22 | -319.75 | -351.92 | -435.55 | -475.84 | -612.19 | -742.87 | -590.52 | -584.08 | -416.5 | -113.63 | -171.79 | -363.61 | -363.47 | -227.93 | -322.44 |
EPS Diluted
| -1.85 | -1.32 | -1.05 | -0.75 | -0.15 | -0.53 | 0.31 | -3.51 | -3.72 | -3.23 | -6.16 | -4.66 | -5.35 | -4.61 | -35.63 | -5.58 | -4.39 | -9.06 | -193.47 | -19.92 | -16.95 | -199.84 | -192.22 | -319.75 | -351.92 | -435.55 | -475.84 | -612.19 | -742.87 | -590.52 | -584.08 | -416.5 | -113.63 | -171.79 | -363.56 | -363.47 | -227.93 | -322.44 |
EBITDA
| -10.078 | -6.877 | -5.663 | -3.893 | -6.878 | -2.435 | -2.577 | -3.102 | -3.214 | -2.863 | -4.566 | -3.452 | -3.914 | -3.318 | -19.503 | -3.049 | -2.385 | -4.733 | -12.709 | -2.318 | -2.349 | -2.8 | -3.478 | -5.906 | -6.534 | -7.064 | -6.567 | -8.539 | -10.515 | -7.498 | -7.228 | -3.401 | -1.84 | -2.222 | -2.315 | -2.372 | -1.609 | 0.227 |
EBITDA Ratio
| 0 | 0 | -1,415.75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |